KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $1.1 million.

  • CareDx's Gains from Investment Securities fell 4922.53% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 million, marking a year-over-year increase of 7850.5%. This contributed to the annual value of $10.1 million for FY2024, which is 22991.17% up from last year.
  • As of Q3 2025, CareDx's Gains from Investment Securities stood at $1.1 million, which was down 4922.53% from $6.2 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Gains from Investment Securities registered a high of $18.0 million during Q4 2021, and its lowest value of -$147000.0 during Q2 2021.
  • Over the past 5 years, CareDx's median Gains from Investment Securities value was $1.1 million (recorded in 2025), while the average stood at $2.5 million.
  • As far as peak fluctuations go, CareDx's Gains from Investment Securities plummeted by 29342.11% in 2021, and later soared by 280161.29% in 2024.
  • Quarter analysis of 5 years shows CareDx's Gains from Investment Securities stood at $18.0 million in 2021, then tumbled by 71.65% to $5.1 million in 2022, then tumbled by 73.98% to $1.3 million in 2023, then surged by 168.6% to $3.6 million in 2024, then crashed by 67.84% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $6.2 million for Q2 2025, and $3.1 million during Q1 2025.